Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov 28:9:621.
doi: 10.3389/fpsyt.2018.00621. eCollection 2018.

Increased Risk of Metabolic Syndrome in Antidepressants Users: A Mini Review

Affiliations
Review

Increased Risk of Metabolic Syndrome in Antidepressants Users: A Mini Review

Carla Gramaglia et al. Front Psychiatry. .

Abstract

Mounting evidence has shown that the risk of metabolic syndrome (MetS) is substantially overlapping in the diagnostic subgroups of psychiatric disorders. While it is widely acknowledged that patients receiving antipsychotic medications are at higher risk of MetS than antipsychotic-naive ones, the association between antidepressants and MetS is still debated. The goal of our mini review was to analyse the relationship among depressive symptoms, antidepressant use and the occurrence of MetS. Adhering to PRISMA guidelines, we searched MEDLINE, reference lists and journals, using the following search string: ((("Mental Disorders"[Mesh]) AND "Metabolic Syndrome"[Mesh]) AND "Antidepressive Agents"[Mesh]), and retrieved 36 records. Two reviewers independently assessed records and the mini review eventually included the data extracted from 8 studies. The Newcastle-Ottawa Scale was used to assess the quality of the selected studies. Overall, the results of the mini review seem to support the association among depressive symptoms, antidepressants therapy and MetS. Except for H1-R high-affinity ones, the relationship between antidepressants and MetS still needs to be clarified. Considering the widespread prescription of antidepressants, both on behalf of psychiatrists and primary care physicians, further research on this topic is recommended.

Keywords: antidepressants; cardiometabolic disease; depression; metabolic syndrome; preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement; review.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA 2009 flow diagram. Adapted from Moher et al. (47).

References

    1. Crichton GE, Elias MF, Robbins MA. Association between depressive symptoms, use of antidepressant medication and the metabolic syndrome: the maine-syracuse study. BMC Public Health. (2016) 16:1–9. 10.1186/s12889-016-3170-2 - DOI - PMC - PubMed
    1. Chokka P, Tancer M, Yeragani VK. Metabolic syndrome: relevance to antidepressant treatment. J Psychiatry Neurosci. (2006) 31:414. - PMC - PubMed
    1. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. . Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International. Circulation. (2009) 120:1640–5. 10.1161/CIRCULATIONAHA.109.192644 - DOI - PubMed
    1. IDF . The IDF consensus worldwide definition of the metabolic syndrome. Available online at: http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf (Accessed June 11, 2011).
    1. Kubrusly M, de Oliveira CMC, Simões PSF, Lima R de O, Galdino PNR, Sousa P de AF, et al. . Prevalence of metabolic syndrome according to NCEP-ATP III and IDF criteria in patients on hemodialysis. J Bras Nefrol. (2015) 37:72–8. 10.5935/0101-2800.20150011 - DOI - PubMed

LinkOut - more resources